WELLS FARGO & COMPANY/MN
Position in DAWN — Day One Biopharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in DAWN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,209,837
+$140,685 QoQ
Shares Held
56,429
-50.8% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 206 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 96.8455935777703.ToString("F0")%
Shared 0.ToString("F0")%
None 3.1544064222297044.ToString("F0")%
Common Shares in DAWN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,850,561 across 389 Biotechnology names. DAWN ranks #87 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in DAWN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,209,837 | 56,429 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,069,152 | 114,716 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $574,348 | 81,468 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $471,685 | 72,567 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $425,808 | 53,696 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $655,481 | 51,735 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $786,752 | 56,479 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $784,577 | 56,936 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $755,971 | 45,761 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $558,085 | 38,225 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $952,286 | 77,611 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,086,074 | 90,961 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $769,549 | 57,558 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $445,915 | 20,721 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $420,209 | 20,979 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $361,794 | 20,212 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $99,200 | 10,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $179,485 | 10,652 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $238,557 | 10,053 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||